tocilizumab

Avtozma is used to treat various inflammatory conditions, including rheumatoid arthritis (RA) in adults, juvenile idiopathic arthritis (JIA s and JIA p) in children and adolescents, giant cell arteritis (GCA) in adults, cytokine release syndrome (CRS), and coronavirus disease 2019 (COVID-19) in patients requiring oxygen or ventilation.

Form: solution for infusion, concentrate

ATC: L04AC07

Manufacturer: CELLTRION HEALTHCARE HUNGARY KFT

RoActemra is used to treat several inflammatory conditions, including rheumatoid arthritis (RA) in adults, juvenile idiopathic arthritis (JIA-s and JIA-p) in children and adolescents, giant cell arteritis (GCA) in adults, cytokine release syndrome (CRS), and coronavirus disease 2019 (COVID-19) in patients requiring oxygen or ventilation.

Form: solution for infusion, concentrate

ATC: L04AC07

Manufacturer: ROCHE REGISTRATION GMBH

Tofidence is used to treat adults with moderate to severe active rheumatoid arthritis (RA) when previous therapies have not been sufficient. It is also indicated for adults with severe, active, and progressive rheumatoid arthritis not previously treated with methotrexate, for children over 2 years of age with systemic juvenile idiopathic arthritis (sJIA) or polyarticular juvenile idiopathic arthritis (pJIA), and for adults with COVID-19 who require oxygen therapy or mechanical ventilation and are receiving corticosteroid therapy.

Form: solution for infusion, concentrate

ATC: L04AC07

Manufacturer: STADA ARZNEIMITTEL AG

Tyenne is used to treat several inflammatory conditions: rheumatoid arthritis (RA) in adults, giant cell arteritis (GCA) in adults, systemic juvenile idiopathic arthritis (sJIA) and polyarticular juvenile idiopathic arthritis (pJIA) in children and adolescents, cytokine release syndrome (CRS), and COVID-19 in patients requiring oxygen or ventilation.

Form: solution for infusion, concentrate

ATC: L04AC07

Manufacturer: FRESENIUS KABI DEUTSCHLAND GMBH